Detalhe da pesquisa
1.
Feasibility of hepatitis C elimination by screening and treatment alone in high-income countries.
Hepatology
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38478751
2.
Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection.
Liver Int
; 44(6): 1383-1395, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445848
3.
An economic evaluation of community pharmacy-dispensed naloxone in Canada.
Can Pharm J (Ott)
; 157(2): 84-94, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38463179
4.
Cost-utility analysis of emicizumab for the treatment of severe hemophilia A patients in Canada.
Haemophilia
; 29(2): 488-497, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528890
5.
Impact of direct-acting antiviral treatment on health utility in patients with chronic hepatitis C in hospital and community settings.
Liver Int
; 43(4): 805-818, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606706
6.
Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study.
CMAJ
; 195(14): E499-E512, 2023 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37040993
7.
Feasibility of hepatitis B elimination in high-income countries with ongoing immigration.
J Hepatol
; 77(4): 947-956, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483535
8.
Cost-effectiveness analysis of hepatitis C virus (HCV) point-of-care assay for HCV screening.
Liver Int
; 42(4): 787-795, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34847288
9.
Time Costs and Out-of-Pocket Costs in Patients With Chronic Hepatitis C in a Publicly Funded Health System.
Value Health
; 25(2): 247-256, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094798
10.
"Bring the Hoses to Where the Fire Is!": Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs.
Value Health
; 25(8): 1307-1316, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35527165
11.
Cost-effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis.
J Viral Hepat
; 28(2): 260-267, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33065774
12.
Lenvatinib Versus Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Cost-Utility Analysis.
Oncologist
; 25(3): e512-e519, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162815
13.
Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population-based cohort studies.
J Viral Hepat
; 27(12): 1419-1429, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810886
14.
Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
Hum Reprod
; 35(2): 434-445, 2020 02 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32099994
15.
The health impact of delaying direct-acting antiviral treatment for chronic hepatitis C: A decision-analytic approach.
Liver Int
; 40(1): 51-59, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31509639
16.
The emergency department as a setting-specific opportunity for population-based hepatitis C screening: An economic evaluation.
Liver Int
; 40(6): 1282-1291, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32267604
17.
A Systematic Review and Meta-Analysis of Health Utilities in Patients With Chronic Hepatitis C.
Value Health
; 23(1): 127-137, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952667
18.
Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis.
Clin Gastroenterol Hepatol
; 17(9): 1840-1849.e16, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30580095
19.
Cost-utility analysis of offering a novel remunerated community pharmacist consultation service on influenza vaccination for seniors in Ontario, Canada.
J Am Pharm Assoc (2003)
; 59(4): 489-497.e1, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30979576
20.
Cost-Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma.
Oncologist
; 23(2): 225-233, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29021380